Englander Institute for Precision Medicine

Publications

Found 785 results
Author Title Type [ Year(Asc)]
2022
Kadri S, Sboner A, Sigaras A, Roy S.  2022.  Containers in Bioinformatics: Applications, Practical Considerations, and Best Practices in Molecular Pathology.. J Mol Diagn. 24(5):442-454.
Marchi S, Morroni G, Pinton P, Galluzzi L.  2022.  Control of host mitochondria by bacterial pathogens.. Trends Microbiol. 30(5):452-465.
Álvarez-Abril B, Bloy N, Galassi C, Sato A, Jiménez-Cortegana C, Klapp V, Aretz A, Guilbaud E, Buqué A, Galluzzi L et al..  2022.  Cytofluorometric assessment of acute cell death responses driven by radiation therapy.. Methods Cell Biol. 172:17-36.
Jiménez-Cortegana C, Klapp V, Bloy N, Galassi C, Sato A, Yamazaki T, Buqué A, Galluzzi L, Petroni G.  2022.  Cytofluorometric assessment of cell cycle progression in irradiated cells.. Methods Cell Biol. 172:1-16.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, E Crawford D, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á et al..  2022.  Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.. N Engl J Med. 386(12):1132-1142.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford D, Manarite J, Muslin D, Farrington T, Tombal B.  2022.  Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial.. Future Oncol. 18(21):2585-2597.
Berchuck JE, Baca SC, McClure HM, Korthauer K, Tsai HK, Nuzzo PVitale, Kelleher KM, He M, Steinharter JA, Zacharia S et al..  2022.  Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.. Clin Cancer Res. 28(5):928-938.
Wittenbecher C, Cuadrat R, Johnston L, Eichelmann F, Jäger S, Kuxhaus O, Prada M, F M DGreco, Hicks AA, Hoffman P et al..  2022.  Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology.. Nat Commun. 13(1):936.
Zhao JL, Fizazi K, Saad F, Chi KN, Taplin M-E, Sternberg CN, Armstrong AJ, de Bono JS, Duggan WT, Scher HI.  2022.  The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial.. Clin Cancer Res. 28(5):860-869.
Wilson BE, Armstrong AJ, de Bono J, Sternberg CN, Ryan CJ, Scher HI, Smith MR, Rathkopf D, Logothetis CJ, Chi KN et al..  2022.  Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302.. Eur J Cancer. 170:296-304.
Meleshko D, Yang R, Marks P, Williams S, Hajirasouliha I.  2022.  Efficient detection and assembly of non-reference DNA sequences with synthetic long reads.. Nucleic Acids Res. 50(18):e108.
Harris AE, Metzler VM, Lothion-Roy J, Varun D, Woodcock CL, Haigh DB, Endeley C, Haque M, Toss MS, Alsaleem M et al..  2022.  Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.. Front Endocrinol (Lausanne). 13:1006101.
de Wit R, Powles T, Castellano D, Necchi A, Lee J-L, van der Heijden MS, Matsubara N, Bamias A, Fléchon A, Sternberg CN et al..  2022.  Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy.. Br J Clin Pharmacol. 88(7):3182-3192.
Mosquera MJ, Kim S, Bareja R, Fang Z, Cai S, Pan H, Asad M, Martin MLaura, Sigouros M, Rowdo FM et al..  2022.  Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.. Adv Mater. 34(2):e2100096.
Jang J-Y, Hwang I, Pan H, Yao J, Alinari L, Imada E, Zanettini C, Kluk MJ, Wang Y, Lee Y et al..  2022.  A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.. J Clin Invest. 132(24)
Pauli C, De Boni L, Pauwels JE, Chen Y, Planas-Paz L, Shaw R, Emerling BM, Grandori C, Hopkins BD, Rubin MA.  2022.  A Functional Precision Oncology Approach to Identify Treatment Strategies for Myxofibrosarcoma Patients.. Mol Cancer Res. 20(2):244-252.
Xu X, Wang K, Vera O, Verma A, Jasani N, Bok I, Elemento O, Du D, Yu X, Karreth FA.  2022.  Gain of Chromosome 1q Perturbs a Competitive Endogenous RNA Network to Promote Melanoma Metastasis.. Cancer Res. 82(17):3016-3031.
Tang CP, Clark O, Ferrarone JR, Campos C, Lalani AS, Chodera JD, Intlekofer AM, Elemento O, Mellinghoff IK.  2022.  GCN2 kinase activation by ATP-competitive kinase inhibitors.. Nat Chem Biol. 18(2):207-215.
Hsiehchen D, Bucheit L, Yang D, Beg MShaalan, Lim M, Lee SS, Kasi PMurtaza, Kaseb AO, Zhu H.  2022.  Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers.. Nat Commun. 13(1):7477.
Punjani N, Kang C, Lamb DJ.  2022.  Genetic Implications of Male-Reproductive-Health-Associated Comorbidities.. Turk J Urol. 48(5):363-374.
van der Mijn JC, Eng KW, Chandra P, Fernandez E, Ramazanoglu S, Sigaras A, Oromendia C, Gudas LJ, Tagawa ST, Nanus DM et al..  2022.  The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.. Mol Oncol. 16(12):2384-2395.
Altorki NK, Borczuk AC, Harrison S, Groner LK, Bhinder B, Mittal V, Elemento O, McGraw TE.  2022.  Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma.. Cell Rep. 39(1):110639.
Brown JA, Sanidad KZ, Lucotti S, Lieber CM, Cox RM, Ananthanarayanan A, Basu S, Chen J, Shan M, Amir M et al..  2022.  Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection.. Gut Microbes. 14(1):2105609.
Yaron TM, Heaton BE, Levy TM, Johnson JL, Jordan TX, Cohen BM, Kerelsky A, Lin T-Y, Liberatore KM, Bulaon DK et al..  2022.  Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication.. Sci Signal. 15(757):eabm0808.
Deshpande AS, Ulahannan N, Pendleton M, Dai X, Ly L, Behr JM, Schwenk S, Liao W, Augello MA, Tyer C et al..  2022.  Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing.. Nat Biotechnol. 40(10):1488-1499.